Adrenergic nervous system influences on the induction of ventricular tachycardia

Annals of Noninvasive Electrocardiology

Volumn 7, Issue 4, 2002, Pages 281-288

  Pellizzón, Oscar A ^a   Beloscar, Juan S ^a   Mariani, Enrique ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Adrenergic nervous system; Chronic Chagasic myocarditis; Ventricular tachycardia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; ISOPRENALINE;

ADRENERGIC SYSTEM; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CHAGAS DISEASE; CLINICAL ARTICLE; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; HEART RATE; HEART VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MENTAL STRESS; MORTALITY; PRIORITY JOURNAL; SUDDEN DEATH;

EID: 0036812084     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2002.tb00176.x     Document Type: Article

References (37)

1. Poole JE, Bardy GH. Sudden cardiac death. In Zipes DP, Jalife J (eds.): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, WB Saunders Co, 1995, pp. 812-832.
2. Martins JB. Assessment of the role of the autonomic nervous system in tachycardia. In Zipes DP, Jalife J (eds.): Cardiac electrophysiology: From cell to bedside. Philadelphia, WB Saunders Co, 1995, pp. 1179-1186.
3. Brownstein SL, Hopson RC, Martins JB, et al. Usefulness of isoproterenol in facilitating atrioventricular nodal reentry tachycardia during electrophysiology testing. Am J Cardiol 1988;61:1037-1041.
4. Interian A, Fernandez P, Robinson E, et al. Long-term effect of propranolol in ventricular tachycardia/fibrillation patients with isoproterenol-dependent inducibility. Circulation 1990;82(Suppl. III):435.
5. Olshansky B, Martins JB. Usefulness of isoproterenol facilitation of ventricular tachycardia induction during extraestimulus testing in predicting effective chronic therapy with beta-adrenergic blockade. Am J Cardiol 1987;59:573-577.
6. Jazayeri MR, VanWyhe G, Avitall B, et al. Isoproterenol reversal of antiarrhythmic effects in patients with sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1989;14:705-711.
7. Sung RJ, Lauer MR. Exercise-induced cardiac arrhythmias. In Zipes DP, Jalife J (eds.): Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, W.B. Saunders Co, 1995, pp. 1013-1023.
8. Mokotoff DM, Quinones MA, Miller RR. Exercise-induced ventricular tachycardia. Chest 1980;71: 10-16.
9. O'Hara GE, Brugada P, Rodriguez LM, et al. Incidence, pathophysiology and prognosis of exercise-induced sustained ventricular tachycardia associated with healed myocardial infarction. Am J Cardiol 1992;70:875-878.
10. Podrid PJ, Venditti FJ, Levine PA, et al. The role of exercise testing in evaluation of arrhythmias. Am J Cardiol 1988;62:24H-33H.
11. Mason JW. A comparison of electrophysiology testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med 1993;329:498-499.
12. Podrid PJ, Graboys TB, Lampert S, et al. Exercise stress testing for exposure of arrhythmias. Circulation 1987;75(Suppl. III):60.
13. Reddy CP, Gettes LS. Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia. Am J Cardiol 1979;44:705-713.
14. Sung RJ, Shen EN, Morady F, et. al. Electrophysiology mechanism of exercise-induce sustained ventricular tachycardia. Am J Cardiol 1983;51:525-530.
15. Brodsky MA, Sato DA, Iseri LT, et al. Ventricular tachyarrhythmia associated with psychological stress. JAMA 1987;257:2064-2067.
16. Coumel, P, Leenhardt A. Mental activity, adrenergic modulation, and cardiac arrhythmias in patients with heart disease. Circulation 1991;83(Suppl. II):II-58-II-70.
17. Specchia G, De Servi S, Falcone C, et al. Mental arithmetic stress testing in patients with coronary artery disease. Am Heart J 1984;108:56-63.
18. Sami M, Chaitman B, Fixher L, et al. Significance of exercise-induced ventricular arrhythmia in stable coronary artery disease. A Coronary Artery Surgery Study project. Am J Cardiol 1984;54:1182-1118.
19. Weiner DA, Levine SR, Klein MD, et al. Ventricular arrhythmias during exercise testing: Mechanism, response to coronary bypass surgery, and prognostic significance. Am J Cardiol 1984;53:1553-1557.
20. Mont L, Seixas T, Brugada P, et. al. Clinical and electrophysiology characteristics of exercise-related idiopathic ventricular tachycardia. Am J Cardiol 1991;68:897-900.
21. Vlay SC. Catecholamine-sensitive ventricular tachycardia. Am Heart J 1987;114:455-461.
22. nd Edition, Philadelphia, Lea and Febiger, 1993, pp. 444.
23. Freedman RA, Swerdlow CD, Echt DS, et al. Facilitation of ventricular tachyarrhythmia induction by isoproterenol. Am J Cardiol 1984;54:765.
24. Brodsky MA, Orlov MV, Allen BJ, et al. Clinical assessment of adrenergic tone and responsiveness to β-blocker therapy in patients with symptomatic ventricular tachycardia and no apparent structural heart disease. Am Heart J 1996;131:51-58.
25. Reich P, DeSilva RA, Lown B, et al. Acute psychological disturbances preceding life-threatening ventricular arrhythmias. JAMA 1981;246:223-235.
26. Brodsky MA, Sato DA, Iseri LT, et al. Ventricular tachyarrhythmia associated with psychological stress. JAMA 1987;257:2064-2067.
27. Inoue H, Zipes DP. Results of sympathetic denervation in the canine heart: Hypersensitivity that may be arrhythmogenic. Circulation 1987;75:877-887.
28. Moncayo A. Research activities of the scientific working group (SWG) on Chagas?disease 1982-1985. Mem Inst Oswaldo Cruz 1986;81(Suppl.):179.
29. Andrade Z. Mechanisms of myocardial damage in Trypanosoma cruzi infection. In: Ciba Symposium 99. Cytopathology of parasitic diseases. London, Pitmann books, 1983, pp. 214.
30. Santos Buch CA, Acosta AM. Pathology of Chagas' disease. In: Inmunology and Pathogenesis of Trypanosomiasis. Boca Ratón, FL:, CRC Press, 1985, pp 145.
31. Koberle F. Pathogenesis of Chagas' disease. In: Elliott K. (ed.) Trypanosomiasis and Leishmaniasis. CIBA, Symposium 20, Amsterdam, Elsevier, 1974, pp. 137-152.
32. Hudson L. Autoimmune phenomena in chronic chagasic cardiopathy. Parasitol Today 1985;1:6-9.
33. Petry K, Eisen H. Chagas' disease: A model for the study of autoimmune diseases. Parasitol Today 1989;5:111-116.
34. Tanowitz HB, Burns ER, Kumar Sinha A, et al. Enhanced platelet adherence and aggregation in Chagas' disease: A potential pathogenic mechanism for cardiomyopathy. Am J Trop Med Hyg 1990;43:274-281.
35. Stanton MS, Tuli MM, Radtke NL, et al. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989;14:1519-1526.
36. Henderson EB, Kahnn JK, Corbett JR, et al. Abnormal I-123-metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192-1199.
37. Cohn JV, Levine TB, Frances GS, et al. Neurohumoral control mechanism in congestive heart failure. Am Heart J 1981;102:509-514.